semaglutide clinical trials near me Wegovy shown to reduce risk of heart attack, stroke in major cardiovascular trial Semaglutide Improves Weight Loss in
Description
2019;doi:10.1080/02699052.2019.1587000
doi: 10.1016/j.tips.2018.07.006 239 MamtaniRPfanzelterNHaynesKFinkelmanBSWangXKeefeSMet al
Overall, 222 participants (79.0%) completed the study treatment, 59 (21.0%) discontinued the study treatment early, and 237 (84.3%) completed the study
Recent health insurance data from France are indicative of an elevated risk of medullary thyroid carcinoma in individuals treated with GLP-1RAs versus other glucose-lowering agents (35 cases, hazard ratio [HR] 1.78 [95% CI 1.043.05]) (78)
The key finding of a 7% survival benefit in patients who continued metformin challenges the current dogma
A.YildizK.et al
